Sphera Funds Management Ltd. Portfolio Holdings

Sphera Funds Management Ltd.

  • $486 Million
  • Q4 2024

Sphera Funds Management Ltd. has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $486 Million distributed in 108 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Teva Pharmaceutical Industries LTD with a value of $34.6M, Bridge Bio Pharma, Inc. with a value of $24.8M, Sanofi with a value of $18.5M, Syndax Pharmaceuticals Inc with a value of $18.3M, and Astrazeneca PLC with a value of $14.7M.

Examining the 13F form we can see an decrease of $59.7M in the current position value, from $545M to 486M.

Sphera Funds Management Ltd. is based out at Tel Aviv, L3

Below you can find more details about Sphera Funds Management Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $486 Million
Healthcare: $354 Million
Technology: $87.7 Million
Communication Services: $20.7 Million
Consumer Cyclical: $13.7 Million
Utilities: $5.35 Million
Basic Materials: $2.5 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.63B
$3.61 Million 0.74% of portfolio
100,000
Q4 2024 New
$20.3B
$3.48 Million 0.72% of portfolio
22,738
Q4 2024 Reduced 7.02%
$8.81B
$3.45 Million 0.71% of portfolio
50,198
Q4 2024 Reduced 21.84%
$792M
$3.42 Million 0.7% of portfolio
271,792
Q4 2024 Added 17.26%
$50.2M
$3.3 Million 0.68% of portfolio
1,191,140
Q3 2024 Reduced 18.57%
$3.39B
$2.93 Million 0.6% of portfolio
36,287
Q3 2024 Added 1,770.46%
$198M
$2.6 Million 0.54% of portfolio
500,491
Q4 2024 New
$51.5B
$2.58 Million 0.53% of portfolio
10,000
Q4 2024 Added 33.33%
$28.3B
$2.5 Million 0.52% of portfolio
55,894
Q4 2024 Added 37.23%
$85.7M
$2.52 Million 0.52% of portfolio
1,502,429
Q4 2024 Reduced 8.81%
$19.5M
$2.45 Million 0.51% of portfolio
1,214,575
Q3 2024 New
$412M
$2.5 Million 0.51% of portfolio
205,000
Q4 2024 Added 10.29%
$148B
$2.39 Million 0.49% of portfolio
90,000
Q3 2023 Reduced 35.71%
$91M
$2.22 Million 0.46% of portfolio
1,012,749
Q2 2024 Added 2.01%
$4.59B
$2.23 Million 0.46% of portfolio
63,821
Q3 2024 Reduced 54.49%
$304M
$2.2 Million 0.45% of portfolio
273,213
Q4 2024 Added 112.79%
$0
$1.79 Million 0.37% of portfolio
1,929,297
Q3 2024 Added 6.34%
$156B
$1.81 Million 0.37% of portfolio
30,000
Q4 2024 New
$138M
$1.74 Million 0.36% of portfolio
455,604
Q4 2024 Added 9.92%
$103M
$1.23 Million 0.25% of portfolio
139,800
Q4 2024 Added 2.36%
$119B
$1.13 Million 0.23% of portfolio
20,000
Q4 2024 New
$109M
$1.04 Million 0.21% of portfolio
251,935
Q4 2024 Added 38.45%
$51.5M
$987,000 0.2% of portfolio
690,272
Q4 2024 New
$40.8M
$927,000 0.19% of portfolio
626,810
Q3 2022 Added 4.99%
$138M
$655,000 0.13% of portfolio
397,177
Q4 2024 New
$154M
$613,000 0.13% of portfolio
324,639
Q4 2024 Reduced 47.64%
$14.2M
$590,000 0.12% of portfolio
1,018,562
Q4 2024 Reduced 5.67%
$182M
$270,000 0.06% of portfolio
177,094
Q4 2024 Reduced 22.02%
$25M
$123,000 0.03% of portfolio
126,328
Q4 2024 Reduced 13.74%
$25.5M
$42,000 0.01% of portfolio
50,000
Q4 2024 Reduced 83.95%
Kezar Life Sciences Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Vistagen Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2023 Added 708.55%
Alumis Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Kyverna Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 52.24%
Aprea Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Alpha Cognition Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Biohaven LTD
-
$0 0.0% of portfolio
-
Q4 2024 Added 17.38%
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 28.29%
Onkure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Engene Holdings Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Ormat Technologies Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Perion Network LTD
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 56.26%
Perspective Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 21.9%
Cybin Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 42.34%
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 39.87%
Gsk PLC
-
$0 0.0% of portfolio
-
Q4 2024 Added 30.0%
Immatics N.V
-
$0 0.0% of portfolio
-
Q3 2020 New
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 30.02%
Cargo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 5.69%

Summary

  • Portfolio
  • No. of Stocks 108
  • Current Value $486 Million
  • Prior Value $545 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 18 stocks
  • Additional Purchases 28 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 36 stocks
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email